300896.SZ
爱美客
SZSE · Healthcare · C 制造业 · CN
CNY 91.40
−1.04%Aug 20, 2026, 12:28 UTC
Aimeike (Imeik Technology) announced its 2026 first-half results: revenue of 1.216 billion yuan, down 6.42% year-on-year; net profit attributable to shareholders of 593 million yuan, down 24.84%; non-GAAP net profit of 531 million yuan, down 24.48%.
Source:Aug 20, 2026, 12:28 UTC
Imeik Technology proposed a cash dividend of 10 yuan per 10 shares (tax included) to all shareholders, based on 301 million shares.
Source:Jul 29, 2026, 09:18 UTC
Aimeike received a medical device registration certificate from the National Medical Products Administration for its medical cross-linked hyaluronic acid-hydroxypropyl methylcellulose gel, effective from July 28, 2026 to July 27, 2031, for improving moderate temporal depression in adults.